Drug Developers Deploy In Silico Drug Safety Prediction Models From Deep Origin’s ARPA-H-Funded PREDICTS Consortium

ImmVue, Synko, Sanford Burnham Prebys, and SyzOnc are deploying Deep Origin's AI-based ADMET prediction tools across millions of compounds to prioritize drug-discovery programs. The adoption highlights growing use of computational screening to improve early-stage biotech research efficiency, though no financial terms, clinical outcomes, or revenue impact were disclosed.